Caris Life Sciences, Inc. (CAI)
About Caris Life Sciences, Inc.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $812.0M
- Net income
- -$68.1M
- Total assets
- $1.1B
- Market cap
- $4.7B
- Operating margin
- 5.6%
- Net margin
- -8.4%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $812.0M
- Operating expenses
- $766.9M
- Operating income
- $45.1M
- Income tax
- $0
- Net income
- -$68.1M
- EPS (basic)
- $-3.22
- EPS (diluted)
- $-3.22
Balance sheet
- Total assets
- $1.1B
- Current assets
- $997.8M
- Total liabilities
- $548.4M
- Current liabilities
- $127.1M
- Shareholders’ equity
- $577.3M
Cash flow
- Operating cash flow
- $83.2M
- Investing cash flow
- -$16.3M
- Financing cash flow
- $665.0M
- Net cash flow
- $731.9M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $4.7B
- EPS (diluted)
- $-3.22
- Dividend yield
- 7.73%
- Shares outstanding
- 300.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 18, 2025
Caris Life Sciences, Inc. (CAI) Stock Price
- Reported a net loss of $68.1M in FY2025.
- Revenue grew 133% from FY2017 to FY2025.
- Trading 61% below its 52-week high.
- Pays a dividend yielding about 7.73% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Caris Life Sciences, Inc..
Write a review
News about Caris Life Sciences, Inc.
News & sentiment via Polygon.io
Caris Life Sciences, Inc.: frequently asked questions
Is Caris Life Sciences, Inc. an American company?
Caris Life Sciences, Inc. is a US-based company headquartered in Irving, Texas, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Caris Life Sciences, Inc. headquartered?
Caris Life Sciences, Inc. is headquartered in Irving, Texas, United States.
Is Caris Life Sciences, Inc. publicly traded?
Yes — Caris Life Sciences, Inc. is a publicly traded company. Its stock trades under the ticker symbol CAI on the NASDAQ.
What does Caris Life Sciences, Inc. do?
Caris Life Sciences, Inc. is an American Medical Devices company in the Health & Beauty sector.
